BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220214
DTEND;VALUE=DATE:20220217
DTSTAMP:20260516T003124
CREATED:20211029T081249Z
LAST-MODIFIED:20211029T081249Z
UID:31932-1644796800-1645055999@www.pharmajournalist.com
SUMMARY:4th Bacteriophage Therapy Summit
DESCRIPTION:From Translation to Market-Entry: Advance Formulation\, Clinical Development\, & Commercialization of Phage-Based Therapies at the 4th Bacteriophage Therapy Summit 2022. \nReturning for its 4th year\, the Bacteriophage Therapy Summit remains the only industry-focused forum dedicated to facilitating the discovery\, translation & acceleration of bacteriophage research into targeted therapeutics with clinically significant results. View the full event guide here: https://ter.li/ehl7e1 \n2022 Agenda Overview: \n\nNavigate clinical trial rationale\, distribution effects of formulation on reaching infection sites\, lessons learned from compassionate use trials\, and the regulatory pathway for commercial development with the hottest insights from our 35+ expert speaker faculty\nHear from international organizations including the FDA\, BiomX\, Locus Bioscience\, Felix Bioscience\, Phagomed\, PhagePro\, Cytophage\, Sciphage and unite with the phage community prioritizing human health and diseas\nDiscuss strategies to weaponize phage therapies including lysins\, genetic engineered and combination approaches to create new pathways for the treatment of infectious diseases\, across 3 days of unparalleled\, industry-centered content\nKeep your company’s interest in bacteriophage therapies up-to-date and aligned with the new breakthroughs beyond basic science and establish your pathway to commercialization in 2022 and beyond\n\nSee our full speaker faculty\, all agenda topics\, and our attending audience in our event brochure: https://ter.li/ehl7e1 \nJoin us to develop the next generation of phage therapy products disrupting the medical and healthcare industries for a better tomorrow. Early booking and group discounts are available upon request. Please visit the website for more information on registration fees and discounts. https://ter.li/1szl1y
URL:https://www.pharmajournalist.com/event/4th-bacteriophage-therapy-summit/
LOCATION:Digital Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220215
DTEND;VALUE=DATE:20220218
DTSTAMP:20260516T003124
CREATED:20211105T123049Z
LAST-MODIFIED:20211105T123049Z
UID:31997-1644883200-1645142399@www.pharmajournalist.com
SUMMARY:2nd Operationalize: Expanded Access Programs Summit
DESCRIPTION:This 2nd Operationalize: Expanded Access Programs summit is here to bring you solutions. \nBy bringing together the world’s leading Expanded Access Programs thinkers\, this exclusive platform will clarify the complex issues through end-to-end Managed Access/Compassionate Use program operationalization. Through open discussion\, sharing best-practice case studies\, and removing hypotheticals: this event provides an unrivaled opportunity to solve your challenges across the entire timeline. \nWhether it’s program set-up\, US and EU regulatory pathways\, product supply\, data collection\, logistics\, ethical considerations\, or internal collaborating – ensure you aren’t repeating past mistakes by hearing global leaders recall their experiences with a shared goal of providing you with pragmatic solutions to solve these complex hurdles. \nFor more information visit: https://ter.li/f41rv0
URL:https://www.pharmajournalist.com/event/2nd-operationalize-expanded-access-programs-summit/
LOCATION:Aloft Boston Seaport District\, 401-403 D St\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR